The Indian Pharmaceutical Market - Leading Domestic Companies 2015
- Submitted by: SophiaJones
- Views: 74
- Category: Other
- Date Submitted: 10/27/2015 03:50 AM
- Pages: 3
- Report this Essay
27th Oct 2015, – Navi Mumbai, India: Market reports on India presents the latest report on “The Indian Pharmaceutical Market - Leading Domestic Companies 2015”. The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Datas list generating over 50% of their annual revenues from the US generics market
This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. http://www.marketreportsonindia.com/life-sciences-market-research-reports-13024/indian-pharmaceutical-leading-domestic.html This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.
The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;
Key Drivers
US Generics Market
JV, Acquisitions & Mergers
Patent Cliff
Increased Domestic Health Spending
Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
Economies in Drug Production/Manufacture
Governmental Support
Key Restraints
Industry Inefficiencies
Regulatory Non-Compliance
Price Ceilings
Intellectual Property Rights / Compulsory Licence
Inadequate Health Insurance, India
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Datas list generating over 50% of their annual revenues from the US generics market....
This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. http://www.marketreportsonindia.com/life-sciences-market-research-reports-13024/indian-pharmaceutical-leading-domestic.html This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.
The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;
Key Drivers
US Generics Market
JV, Acquisitions & Mergers
Patent Cliff
Increased Domestic Health Spending
Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
Economies in Drug Production/Manufacture
Governmental Support
Key Restraints
Industry Inefficiencies
Regulatory Non-Compliance
Price Ceilings
Intellectual Property Rights / Compulsory Licence
Inadequate Health Insurance, India
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Datas list generating over 50% of their annual revenues from the US generics market....